NCT04631250View on ClinicalTrials.gov

Conventional Photodynamic Therapy Versus Daylight Photodynamic Therapy for The Treatment of Acne Vulgaris

NACompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

November 1, 2018

Primary Completion Date

July 1, 2020

Study Completion Date

July 1, 2020

Conditions
Acne Vulgaris
Interventions
DRUG

5-Aminolevulinic Acid-Containing Product in Cutaneous Dose Form

5-Aminolevulinic Acid was applied to both sides of the face.

Trial Locations (1)

6423906

Tel Aviv Sourasky Medical Center, Tel Aviv

All Listed Sponsors
lead

Tel-Aviv Sourasky Medical Center

OTHER_GOV

NCT04631250 - Conventional Photodynamic Therapy Versus Daylight Photodynamic Therapy for The Treatment of Acne Vulgaris | Biotech Hunter | Biotech Hunter